Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
22 Aprile 2024 - 2:00PM
Business Wire
Company marks significant progress towards
climate goals, reaching the milestone considerably ahead of
schedule
Charles River Laboratories International, Inc. (NYSE: CRL) today
announced it has reached 100 percent renewable electricity across
all of its global sites as of the first quarter of 2024,
significantly ahead of the original target date. In 2020, Charles
River became one of the first 300 members of RE100, a global
corporate renewable energy initiative, and committed to operating
on 100 percent renewable electricity globally by 2030. Today,
Charles River joins a small group of leading companies that have
achieved this goal organization-wide in accordance with RE100’s
standardized reporting criteria1.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240422679591/en/
In efforts to reach its renewable electricity target, Charles
River has:
- Executed two critical virtual power purchase agreements
(vPPAs) in the United States and Europe. In 2020, the Company
initiated a 15-year contract with Deriva Energy for a 102-megawatt
solar vPPA located in Texas, which, as of January 2023, provides
100 percent of its North American electric power requirements with
clean, renewable energy. Further, in 2023, Charles River’s 12-year,
30-megawatt wind power vPPA went live, which is a partnership with
Spain-based Repsol, a multi-energy company, and covers the
organization’s entire European electricity load.
- Partnered with leading organizations to drive the adoption
of green energy solutions. In 2022, Charles River was
recognized by the U.S. Environmental Protection Agency’s Green
Power Partnership as a leader in green electricity use. Last year,
the company joined the Renewable Thermal Collaborative, a global
coalition of companies, institutions, and governments committed to
scaling up renewable energy for heating and cooling. Charles River
also sponsored Energize, a program powered by Schneider Electric to
increase access to renewable energy for pharmaceutical supply
chains.
- Invested $13.5 million in sustainability-focused projects
through the Charles River Sustainability Capital Fund. From
2020-2023, Charles River has funded over 100 projects globally that
reduce its environmental footprint, including energy conservation
and GHG reduction efforts.
- Reduced GHG Emissions from its facilities significantly.
As of year-end 2023, Charles River had achieved a 37 percent
reduction in GHG emissions from its facilities (Scope 1 and 2
emissions). With the increase to 100 percent renewable electricity
in 2024, Charles River is targeting a 45 percent reduction by
year-end 2024, making progress towards its goal of a 50 percent
reduction by 2030.
To learn more about Charles River’s commitment to protecting the
planet, visit the Corporate Citizenship webpage.
_________________________ 1 RE100 Annual Disclosure Report
2023
Approved Quotes
- “At Charles River, we are guided by our purpose of Creating
Healthier Lives, which extends beyond science – because healthy
lives start with a healthy planet. Today’s announcement marks a
milestone in our commitment to supporting sustainable business
practices and driving marked change for our clients, partners,
communities, and planet.” –James C. Foster, Chairman, President and
Chief Executive Officer, Charles River
- “As we celebrate Earth Day this month, now is an exciting time
to achieve our goal of operating on 100 percent renewable
electricity globally. We’re proud to be a part of the small group
of elite organizations to reach this target, driving change by
committing to and achieving bold and ambitious environmental
sustainability goals.” –Gregg Belardo, Executive Director, Global
EHS and Sustainability, Charles River
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240422679591/en/
Charles River Investor Contact: Todd Spencer Corporate
Vice President, Investor Relations 781.222.6455
todd.spencer@crl.com
Charles River Media Contact: Amy Cianciaruso Corporate
Vice President, Chief Communications Officer 781.222.6168
amy.cianciaruso@crl.com
Grafico Azioni Charles River Laboratories (NYSE:CRL)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Charles River Laboratories (NYSE:CRL)
Storico
Da Giu 2023 a Giu 2024